TET2 and chronic myelomonocytic leukemia: Additionally, the TET2 mutation was found to confer a favorable prognosis in CMML [79], but in MF/MPF, it was associated with an increased risk of thrombosis [80] and monocytic differentiation with a comparatively smaller prognostic significance in survival [81].